DOCSLIB.ORG

Electronic Supplementary Material (ESI) for Molecular Omics. This Journal Is © the Royal Society of Chemistry 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Electronic Supplementary Material (ESI) for Molecular Omics. This Journal Is © the Royal Society of Chemistry 2018 Electronic Supplementary Material (ESI) for Molecular Omics. This journal is © The Royal Society of Chemistry 2018 Supplementary Table 1 Biological Rep 1 Biological Rep 2 Biological Rep 3 Fold change w.r.t Control Fold change w.r.t Control Fold change w.r.t Control % CV No. of No. of No. of Acession ID Description peptides Tm 4-PBA 4-PBA+Tm peptides Tm 4-PBA 4-PBA+Tm peptides Tm 4-PBA 4-PBA+Tm Tm 4-PBA 4-PBA+Tm Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 Q14204 PE=1 SV=5 195 1.04 1.01 1.04 171 0.96 0.98 0.97 165 1.03 1.02 1.03 4.27 2.06 3.81 DNA-dependent protein kinase catalytic subunit OS=Homo sapiens P78527 GN=PRKDC PE=1 SV=3 185 0.93 1.01 0.96 149 0.93 0.99 0.94 139 0.93 0.97 0.95 0.48 2.03 0.92 Q60FE2 MYH9 variant protein OS=Homo sapiens GN=MYH9 PE=2 SV=1 151 1.16 0.99 1.17 138 1.19 1.01 1.20 137 1.15 1.00 1.19 1.49 0.97 1.46 Q60FE6 Filamin A OS=Homo sapiens GN=FLNA PE=2 SV=1 132 1.07 0.98 1.13 119 1.05 0.98 1.14 108 1.07 0.97 1.14 1.01 0.91 0.65 P49327 Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=3 134 0.80 0.96 0.87 96 0.82 0.94 0.87 87 0.83 0.97 0.88 2.09 1.93 0.80 Spectrin beta non-erythrocytic 1 OS=Homo sapiens GN=SPTBN1 PE=2 B2ZZ89 SV=1 103 0.98 0.99 0.97 90 0.94 0.95 0.93 73 1.02 1.04 1.01 4.15 4.78 4.13 Q00610 Clathrin heavy chain 1 OS=Homo sapiens GN=CLTC PE=1 SV=5 144 0.95 1.00 1.02 127 0.94 0.97 0.94 112 0.96 1.02 0.97 0.88 2.61 3.99 Q9Y490 Talin-1 OS=Homo sapiens GN=TLN1 PE=1 SV=3 114 1.03 0.96 1.08 121 0.96 0.91 0.99 81 1.03 1.02 1.03 3.98 5.81 4.13 Peroxisome proliferator activated receptor interacting complex protein E1NZA1 OS=Homo sapiens GN=PRIC295 PE=2 SV=1 85 0.94 1.02 0.95 65 0.96 1.03 0.98 67 0.93 0.97 0.94 1.53 3.19 2.52 Microtubule-associated protein 1B OS=Homo sapiens GN=MAP1B PE=1 P46821 SV=2 99 1.03 0.97 0.97 70 1.08 1.02 1.11 85 1.05 0.95 1.01 2.24 3.81 6.57 U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens O75643 GN=SNRNP200 PE=1 SV=2 77 0.89 0.94 0.87 79 0.87 0.96 0.93 60 0.84 0.95 0.88 2.62 0.75 3.75 Leucine-rich PPR-motif containing OS=Homo sapiens GN=LRPPRC PE=2 E5KNY5 SV=1 93 0.94 1.02 0.98 91 0.93 1.00 0.94 82 0.93 0.98 0.97 0.62 2.01 2.07 Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 Q6P2Q9 PE=1 SV=2 72 0.88 0.95 0.94 61 0.92 0.97 0.94 64 0.92 1.01 0.95 2.63 3.01 1.13 Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens Q09666 GN=AHNAK PE=1 SV=2 66 1.02 1.07 1.00 61 1.09 1.10 1.04 45 1.05 1.04 1.04 3.27 3.11 2.29 Heat shock protein HSP 90-beta OS=Homo sapiens GN=HSP90AB1 PE=1 P08238 SV=4 142 0.83 0.96 0.88 123 0.87 1.04 0.89 122 1.35 1.22 1.21 28.44 12.42 18.96 O75369 Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 73 1.02 1.01 1.02 67 1.04 1.02 1.09 57 1.03 1.04 1.13 0.61 1.73 5.36 P12814 Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2 78 1.14 0.99 1.12 87 1.14 1.06 1.19 80 1.14 0.98 1.13 0.14 3.86 3.13 P13639 Elongation factor 2 OS=Homo sapiens GN=EEF2 PE=1 SV=4 129 0.87 1.01 0.91 96 0.95 1.06 0.97 93 0.88 0.96 0.93 4.54 5.35 3.57 NUMA1 variant protein (Fragment) OS=Homo sapiens GN=NUMA1 variant Q4LE64 protein PE=2 SV=1 70 0.80 0.95 0.84 57 0.87 0.93 0.86 49 0.81 0.96 0.87 5.09 1.74 1.74 IQ motif containing GTPase activating protein 1 OS=Homo sapiens A4QPB0 GN=IQGAP1 PE=2 SV=1 65 1.03 1.00 1.10 57 0.95 0.93 0.99 50 0.99 1.03 1.01 4.18 5.34 5.85 P09874 Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 66 0.87 1.01 0.86 56 0.95 1.08 0.96 54 0.89 0.97 0.92 4.43 5.30 5.26 P14618 Pyruvate kinase PKM OS=Homo sapiens GN=PKM PE=1 SV=4 115 1.01 0.98 1.06 90 0.97 0.94 0.98 97 0.97 0.98 0.98 2.45 2.71 4.26 Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS P07814 PE=1 SV=5 55 1.06 0.99 1.01 46 1.07 1.05 1.12 44 1.07 0.97 1.06 0.47 4.09 5.35 Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens GN=UBA1 P22314 PE=1 SV=3 79 1.00 1.01 0.99 63 1.01 0.98 0.97 54 1.01 1.05 1.02 0.46 3.45 2.80 E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 Q7Z6Z7 SV=3 42 1.01 0.99 1.03 35 0.99 0.91 0.94 27 0.96 1.05 0.96 2.26 6.77 4.68 78 kDa glucose-regulated protein OS=Homo sapiens GN=HSPA5 PE=1 P11021 SV=2 116 3.47 1.00 2.64 102 3.17 0.96 2.47 106 3.09 1.11 2.63 6.15 7.32 3.59 Q08211 ATP-dependent RNA helicase A OS=Homo sapiens GN=DHX9 PE=1 SV=4 63 0.89 0.96 0.97 61 0.91 0.94 0.95 59 0.94 0.96 0.95 2.91 1.34 1.03 B0V043 Valine--tRNA ligase OS=Homo sapiens GN=VARS PE=2 SV=1 50 0.93 1.04 0.99 31 1.01 1.05 0.98 27 0.93 1.00 0.93 5.08 2.87 3.22 Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP P55072 PE=1 SV=4 66 1.03 1.03 1.05 66 1.02 0.97 1.01 57 1.03 1.03 1.06 0.60 3.41 2.65 Q9BQG0 Myb-binding protein 1A OS=Homo sapiens GN=MYBBP1A PE=1 SV=2 48 0.92 1.00 0.92 37 0.94 0.96 0.96 32 0.86 0.94 0.85 4.82 3.25 6.08 P30101 Protein disulfide-isomerase A3 OS=Homo sapiens GN=PDIA3 PE=1 SV=4 111 1.91 0.98 1.45 81 1.94 1.01 1.56 85 1.85 1.06 1.65 2.34 3.66 6.20 O00410 Importin-5 OS=Homo sapiens GN=IPO5 PE=1 SV=4 67 1.00 1.03 1.09 44 0.93 0.98 0.94 45 0.94 1.02 0.93 3.57 2.58 9.03 DNA fragmentation factor subunit beta OS=Homo sapiens GN=CAD PE=2 F8VPD4 SV=1 54 0.96 0.93 0.91 32 0.98 1.04 1.00 35 0.96 0.99 0.92 1.06 5.48 5.10 Q14315 Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 54 1.23 1.04 1.16 48 1.16 0.95 1.21 48 1.12 0.98 1.18 5.03 4.47 2.37 P53621 Coatomer subunit alpha OS=Homo sapiens GN=COPA PE=1 SV=2 43 1.02 1.03 1.03 46 1.04 1.07 1.06 40 1.05 0.96 1.04 1.16 5.60 1.45 P12270 Nucleoprotein TPR OS=Homo sapiens GN=TPR PE=1 SV=3 48 0.95 0.95 0.97 37 0.94 0.99 0.97 40 0.98 1.01 0.99 2.31 2.88 1.44 Q86UP2 Kinectin OS=Homo sapiens GN=KTN1 PE=1 SV=1 48 0.98 0.99 0.96 35 1.07 1.07 1.04 32 1.02 0.95 1.01 4.27 6.09 4.01 Isoleucyl-tRNA synthetase, cytoplasmic variant (Fragment) OS=Homo Q59G75 sapiens PE=2 SV=1 42 1.08 0.99 0.99 35 1.02 0.97 1.01 33 1.03 1.09 1.06 3.39 6.61 3.48 Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 P11142 SV=1 129 0.81 0.97 0.84 122 0.85 1.02 0.89 106 0.71 0.88 0.91 9.37 7.69 4.03 O75533 Splicing factor 3B subunit 1 OS=Homo sapiens GN=SF3B1 PE=1 SV=3 43 0.89 0.96 0.91 33 0.92 1.01 1.00 32 0.93 0.95 0.91 2.59 2.85 5.55 Q5SU16 Beta 5-tubulin OS=Homo sapiens GN=TUBB PE=2 SV=1 283 0.84 1.01 0.94 235 0.84 0.93 0.83 238 0.87 1.00 0.91 1.65 4.72 5.92 P08670 Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4 96 1.19 1.02 1.18 84 1.13 1.02 1.17 87 1.18 1.04 1.28 2.80 1.40 4.97 cDNA FLJ44436 fis, clone UTERU2019706, highly similar to T-complex B3KX11 protein 1 subunit gamma OS=Homo sapiens PE=2 SV=1 53 1.10 1.01 1.15 51 0.91 0.99 0.92 38 0.95 1.01 0.95 10.66 1.28 12.46 EIF4G1 variant protein (Fragment) OS=Homo sapiens GN=EIF4G1 variant Q4LE58 protein PE=2 SV=1 43 0.93 1.00 0.95 39 0.96 1.02 1.00 35 0.86 0.94 0.97 5.55 4.17 2.74 P34932 Heat shock 70 kDa protein 4 OS=Homo sapiens GN=HSPA4 PE=1 SV=4 56 0.93 0.99 0.98 43 0.93 0.98 0.95 33 0.92 1.03 0.97 0.61 2.62 1.89 O14980 Exportin-1 OS=Homo sapiens GN=XPO1 PE=1 SV=1 50 0.94 1.02 1.03 35 0.97 1.03 0.97 36 0.98 1.04 0.98 1.81 0.90 3.18 Proteasome 26S non-ATPase subunit 2 variant (Fragment) OS=Homo Q59EG8 sapiens PE=2 SV=1 54 0.93 0.96 0.98 40 1.02 1.01 1.02 34 0.98 0.96 0.96 4.89 2.73 3.29 ACLY variant protein (Fragment) OS=Homo sapiens GN=ACLY variant Q4LE36 protein PE=2 SV=1 39 0.91 0.93 0.92 35 1.00 1.01 0.98 47 0.92 0.99 0.96 5.29 3.99 3.39 Q6IAT1 GDI2 protein OS=Homo sapiens GN=GDI2 PE=2 SV=1 61 0.92 1.02 0.97 53 0.90 0.98 0.92 41 0.91 1.01 0.95 1.00 2.12 2.69 cDNA FLJ54365, highly similar to DNA replication licensing factor MCM4 B4DLA6 OS=Homo sapiens PE=2 SV=1 41 0.86 1.00 0.89 41 0.88 1.00 0.91 30 0.87 0.94 0.87 1.14 3.10 2.01 P13667 Protein disulfide-isomerase A4 OS=Homo sapiens GN=PDIA4 PE=1 SV=2 82 2.30 1.00 1.85 57 2.27 0.99 1.85 61 2.11 1.07 1.82 4.53 4.03 0.74 P53618 Coatomer subunit beta OS=Homo sapiens GN=COPB1 PE=1 SV=3 35 1.01 1.07 1.00 39 1.06 1.04 1.05 37 1.09 1.03 1.07 3.76 1.84 3.65 X-ray repair cross-complementing protein 5 OS=Homo sapiens GN=XRCC5 P13010 PE=1 SV=3 46 0.95 0.98 0.91 37 0.97 1.00 0.96 33 0.95 0.95 0.94 1.42 2.66 2.78 Q92598 Heat shock protein 105 kDa OS=Homo sapiens GN=HSPH1 PE=1 SV=1 55 0.86 0.97 0.87 43 0.86 1.02 0.90 37 0.91 1.01 0.92 3.31 2.93 2.98 P78371 T-complex protein 1 subunit beta OS=Homo sapiens GN=CCT2 PE=1 SV=4 55 0.93 1.05 0.94 55 0.98 1.00 0.94 51 0.98 1.00 0.99 2.86 3.27 3.02 Q6IBM8 U5-116KD protein OS=Homo sapiens GN=U5-116KD PE=2 SV=1 34 0.95 0.96 0.98 31 0.90 1.03 0.96 29 0.96 1.01 0.98 3.49 3.46 1.23 E7EX90 Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=2 SV=1 33 0.51 0.51 1.17 36 1.41 0.87 1.40 26 0.66 0.92 0.77 55.89 29.01 28.37 Eukaryotic translation initiation factor 3 subunit A OS=Homo sapiens Q24JU4 GN=EIF3A PE=2 SV=1 31 0.95 0.99 0.85 29 0.97 1.03 0.97 26 0.96 0.97 1.00 1.40 3.06 8.20 P55060 Exportin-2 OS=Homo sapiens GN=CSE1L PE=1 SV=3 42 0.93 1.01 1.01 40 0.91 0.99 0.94 37 0.93 1.08 0.97 1.42 4.61 3.57 cDNA FLJ55916, highly similar to General transcription factor II-I OS=Homo B4DH52 sapiens PE=2 SV=1 39 0.83 0.96 0.76 38 0.92 1.03 0.91 33 0.84 0.93 0.84 6.19 5.31 9.45 Epididymis tissue sperm binding protein Li 14m OS=Homo sapiens PE=2 E9KL44 SV=1 49 1.06 1.01 1.08 29 1.06 1.02 1.03 34 1.08 1.03 1.05 1.20 1.08 2.34 Q16531 DNA damage-binding protein 1 OS=Homo sapiens GN=DDB1 PE=1 SV=1 34 0.93 1.03 1.04 25 0.92 1.05 0.95 22 0.89 0.96 0.92 2.42 4.43 6.42 Dihydropyrimidinase-like 2 variant (Fragment) OS=Homo sapiens PE=2 Q59GB4 SV=1 70 0.86 0.98 0.87 56 0.93 0.92 0.98 55 0.92 0.95 0.94 4.17 3.11 5.87 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens P04406 GN=GAPDH PE=1 SV=3 241 0.99 1.01 0.90 129 1.03 1.03 1.00 131 1.02 0.97 1.01 1.79 3.25 6.18 E9PDF6
Load more

Recommended publications
  • C8cc08685k1.Pdf
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2018 Supporting Information Minimalist Linkers Suitable for Irreversible Inhibitors in Simultaneous Proteome Profiling, Live-Cell Imaging and Drug Screening Cuiping Guo,Yu Chang, Xin Wang, Chengqian Zhang, Piliang Hao*, Ke Ding and Zhengqiu Li* School of Pharmacy, Jinan University, Guangzhou, China 510632 *Corresponding author ([email protected]) 1. General Information All chemicals were purchased from commercial vendors and used without further purification, unless indicated otherwise. All reactions requiring anhydrous conditions were carried out under argon or nitrogen atmosphere using oven-dried glassware. AR-grade solvents were used for all reactions. Reaction progress was monitored by TLC on pre-coated silica plates (Merck 60 F254 nm, 0.25 µm) and spots were visualized by UV, iodine or other suitable stains. Flash column chromatography was carried out using silica gel (Qingdao Ocean). All NMR spectra (1H-NMR, 13C-NMR) were recorded on Bruker 300 MHz/400 MHz NMR spectrometers. Chemical shifts were reported in parts per million (ppm) referenced with respect to appropriate internal standards or residual solvent peaks (CDCl3 = 7.26 ppm, DMSO-d6 = 2.50 ppm). The following abbreviations were used in reporting spectra, br s (broad singlet), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublets). Mass spectra were obtained on Agilent LC-ESI-MS system. All analytical HPLC were carried out on Agilent system. Water with 0.1% TFA and acetonitrile with 0.1% TFA were used as eluents and the flow rate was 0.5 mL/min.
    [Show full text]
  • Multiplexed Single-Cell Transcriptional Response Profiling to Define Cancer
    ARTICLE https://doi.org/10.1038/s41467-020-17440-w OPEN Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action James M. McFarland 1,11, Brenton R. Paolella 1,11, Allison Warren1, Kathryn Geiger-Schuller 1,2, Tsukasa Shibue1, Michael Rothberg1, Olena Kuksenko1,2, William N. Colgan 1, Andrew Jones1, Emily Chambers1, Danielle Dionne1,2, Samantha Bender1, Brian M. Wolpin3,4,5, Mahmoud Ghandi 1, Itay Tirosh2,6, Orit Rozenblatt-Rosen1,2, Jennifer A. Roth1, Todd R. Golub 1,3,7,8, Aviv Regev 1,2,8,9,10, ✉ ✉ ✉ Andrew J. Aguirre 1,3,4,5,12 , Francisca Vazquez 1,12 & Aviad Tsherniak 1,12 1234567890():,; Assays to study cancer cell responses to pharmacologic or genetic perturbations are typically restricted to using simple phenotypic readouts such as proliferation rate. Information-rich assays, such as gene-expression profiling, have generally not permitted efficient profiling of a given perturbation across multiple cellular contexts. Here, we develop MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation responses across a mixture of samples with single-cell resolution, using SNP-based computational demultiplexing of single- cell RNA-sequencing data. We show that MIX-Seq can be used to profile responses to chemical or genetic perturbations across pools of 100 or more cancer cell lines. We combine it with Cell Hashing to further multiplex additional experimental conditions, such as post- treatment time points or drug doses. Analyzing the high-content readout of scRNA-seq reveals both shared and context-specific transcriptional response components that can identify drug mechanism of action and enable prediction of long-term cell viability from short- term transcriptional responses to treatment.
    [Show full text]
  • The Rise and Fall of the Bovine Corpus Luteum
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
    [Show full text]
  • Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
    Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10.
    [Show full text]
  • Reprogramming of Trna Modifications Controls the Oxidative Stress Response by Codon-Biased Translation of Proteins
    Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Chan, Clement T.Y. et al. “Reprogramming of tRNA Modifications Controls the Oxidative Stress Response by Codon-biased Translation of Proteins.” Nature Communications 3 (2012): 937. As Published http://dx.doi.org/10.1038/ncomms1938 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/76775 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins Clement T.Y. Chan,1,2 Yan Ling Joy Pang,1 Wenjun Deng,1 I. Ramesh Babu,1 Madhu Dyavaiah,3 Thomas J. Begley3 and Peter C. Dedon1,4* 1Department of Biological Engineering, 2Department of Chemistry and 4Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; 3College of Nanoscale Science and Engineering, University at Albany, SUNY, Albany, NY 12203 * Corresponding author: PCD, Department of Biological Engineering, NE47-277, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; tel 617-253-8017; fax 617-324-7554; email [email protected] 2 ABSTRACT Selective translation of survival proteins is an important facet of cellular stress response. We recently demonstrated that this translational control involves a stress-specific reprogramming of modified ribonucleosides in tRNA.
    [Show full text]
  • Protein Name Accession Number Molecular Weight Myovi-GTD
    MyoVI-GTD MyoVI-GTD MyoVa-MGT MyoVa-MGT Molecular Spectral Unique Spectral Unique Protein Name Accession Number Weight Counts Peptides Counts Peptides Dync1h1 Cytoplasmic dynein 1 heavy chain 1 IPI00119876 532 kDa 310 121 515 182 Spna2 Spectrin alpha 2 IPI00757353 285 kDa 853 170 597 149 Myo5a 215 kDa protein IPI00875222 215 kDa 162 47 874 109 AU042671 hypothetical protein LOC269700 isoform 1 IPI00762814 453 kDa 2 2 231 104 Spnb2 Isoform 1 of Spectrin beta chain, brain 1 IPI00319830 274 kDa 505 122 347 100 Dmxl2 Isoform 1 of DmX-like protein 2 IPI00853932 338 kDa 63 38 251 100 Cltc Clathrin heavy chain 1 IPI00169916 (+1) 192 kDa 1994 138 565 90 Mtap2 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530026F16 product:microtubule-associated protein 2, full insert sequenceIPI00894724 199 kDa 229 82 258 74 Mtap1a Isoform 1 of Microtubule-associated protein 1A IPI00408909 (+1) 300 kDa 310 86 214 74 Itpr1 Isoform 4 of Inositol 1,4,5-trisphosphate receptor type 1 IPI00230019 (+3) 311 kDa 37 18 155 73 Huwe1 HECT, UBA and WWE domain containing 1 IPI00463909 (+1) 483 kDa 5 5 91 69 Fasn Fatty acid synthase IPI00113223 272 kDa 24 17 140 68 Usp9x Ubiquitin carboxyl-terminal hydrolase IPI00798468 291 kDa 68 45 98 65 Lrp1 Prolow-density lipoprotein receptor-related protein 1 precursor IPI00119063 505 kDa 92 53 109 62 Myh10 Myosin-10 IPI00515398 (+1) 229 kDa 65 40 98 59 Mical1 NEDD9-interacting protein with calponin homology and LIM domains IPI00116371 117 kDa 2 2 203 57 Plec1 Isoform PLEC-1I of Plectin-1 IPI00229509 (+10)
    [Show full text]
  • Dissert 1 Title
    GENETIC AND BIOCHEMICAL ANALYSIS OF ESSENTIAL ENZYMES IN TRIACYLGLYCEROL SYNTHESIS IN ARABIDOPSIS By KIMBERLY LYNN COTTON A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY WASHINGTON STATE UNIVERSITY Molecular Plant Sciences DECEMBER 2015 © Copyright by KIMBERLY LYNN COTTON, 2015 All Rights Reserved To the Faculty of Washington State University: The members of the Committee appointed to examine the dissertation of KIMBERLY LYNN COTTON find it satisfactory and recommend that it be accepted. ____________________________________________ John A. Browse, Ph.D., Chair _____________________________________________ Michael M. Neff, Ph.D. _____________________________________________ Thomas W. Okita, Ph.D. _____________________________________________ John J. Wyrick, Ph.D. ii ACKNOWLEDGMENTS To my PI John Browse, thank you for your support, guidance and patience over the years. To my committee, John Browse, Michael Neff, Thomas Okita, and John Wyrick, thank you for your insightful discussions and suggestions. To my collaborators Jay Shockey, Anushobha Regmi, Neil Adhikari, John Browse, and Phil Bates, thanks for the great work and great times. To Browse Lab members past and present, thanks for the help, guidance and wonderful memories. To the undergraduate students who have helped me over the years, thank you for all your help in making this project possible; and with a special thank you to Arlene, Tesa, Breana, and “no-longer-undergrads” David and Barbara Cotton for their particular dedication to this project. And finally, a huge thank you to my family and friends who have loved and supported me throughout this venture. Go Cougs! iii GENETIC AND BIOCHEMICAL ANALYSIS OF ESSENTIAL ENZYMES IN TRIACYLGLYCEROL SYNTHESIS IN ARABIDOPSIS Abstract by Kimberly Lynn Cotton, Ph.D.
    [Show full text]
  • Allele-Specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish
    Allele-specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish by Ailu Chen A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Auburn, Alabama August 1, 2015 Keywords: catfish, interspecific hybrids, allele-specific expression, ribosomal protein Copyright 2015 by Ailu Chen Approved by Zhanjiang Liu, Chair, Professor, School of Fisheries, Aquaculture and Aquatic Sciences Nannan Liu, Professor, Entomology and Plant Pathology Eric Peatman, Associate Professor, School of Fisheries, Aquaculture and Aquatic Sciences Aaron M. Rashotte, Associate Professor, Biological Sciences Abstract Interspecific hybridization results in a vast reservoir of allelic variations, which may potentially contribute to phenotypical enhancement in the hybrids. Whether the allelic variations are related to the downstream phenotypic differences of interspecific hybrid is still an open question. The recently developed genome-wide allele-specific approaches that harness high- throughput sequencing technology allow direct quantification of allelic variations and gene expression patterns. In this work, I investigated allele-specific expression (ASE) pattern using RNA-Seq datasets generated from interspecific catfish hybrids. The objective of the study is to determine the ASE genes and pathways in which they are involved. Specifically, my study investigated ASE-SNPs, ASE-genes, parent-of-origins of ASE allele and how ASE would possibly contribute to heterosis. My data showed that ASE was operating in the interspecific catfish system. Of the 66,251 and 177,841 SNPs identified from the datasets of the liver and gill, 5,420 (8.2%) and 13,390 (7.5%) SNPs were identified as significant ASE-SNPs, respectively.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • A Chemical-Genetic Screen for Identifying Substrates of the Er Kinase Perk
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2014 A Chemical-Genetic Screen for Identifying Substrates of the Er Kinase Perk Nancy L. Maas University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Biology Commons, Cell Biology Commons, and the Molecular Biology Commons Recommended Citation Maas, Nancy L., "A Chemical-Genetic Screen for Identifying Substrates of the Er Kinase Perk" (2014). Publicly Accessible Penn Dissertations. 1354. https://repository.upenn.edu/edissertations/1354 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1354 For more information, please contact [email protected]. A Chemical-Genetic Screen for Identifying Substrates of the Er Kinase Perk Abstract Cells constantly encounter changing environments that challenge the ability to adapt and survive. Signal transduction networks enable cells to appropriately sense and respond to these changes, and are often mediated through the activity of protein kinases. Protein kinases are a class of enzyme responsible for regulating a broad spectrum of cellular functions by transferring phosphate groups from ATP to substrate proteins, thereby altering substrate activity and function. PERK is a resident kinase of the endoplasmic reticulum, and is responsible for sensing perturbations in the protein folding capacity of the ER. When the influx of unfolded, nascent proteins exceeds the folding capacity of the ER, PERK initiates a cascade of signaling events that enable cell adaptation and ER stress resolution. These signaling pathways are not only essential for the survival of normal cells undergoing ER stress, but are also co-opted by tumor cells in order to survive the oxygen and nutrient-restricted conditions of the tumor microenvironment.
    [Show full text]
  • Construction of Prognostic Microrna Signature for Human Invasive Breast Cancer by Integrated Analysis
    Journal name: OncoTargets and Therapy Article Designation: Original Research Year: 2019 Volume: 12 OncoTargets and Therapy Dovepress Running head verso: Shi et al Running head recto: Shi et al open access to scientific and medical research DOI: 189265 Open Access Full Text Article ORIGINAL RESEARCH Construction of prognostic microRNA signature for human invasive breast cancer by integrated analysis This article was published in the following Dove Medical Press journal: OncoTargets and Therapy Wei Shi* Background: Despite the advances in early detection and treatment methods, breast cancer Fang Dong* still has a high mortality rate, even in those patients predicted to have a good prognosis. The Yujia Jiang purpose of this study is to identify a microRNA signature that could better predict prognosis in Linlin Lu breast cancer and add new insights to the current classification criteria. Changwen Wang Materials and methods: We downloaded microRNA sequencing data along with correspond- Jie Tan ing clinicopathological data from The Cancer Genome Atlas (TCGA). Of 1,098 breast cancer patients identified, 253 patients with fully characterized microRNA profiles were selected for Wen Yang analysis. A three-microRNA signature was generated in the training set. Subsequently, the per- Hui Guo formance of the signature was confirmed in a validation set. After construction of the signature, Jie Ming* we conducted additional experiments, including flow cytometry and the Cell Counting Kit-8 Tao Huang* assay, to illustrate the correlation of this microRNA signature with breast cancer cell cycle, Department of Breast and Thyroid apoptosis, and proliferation. Surgery, Union Hospital, Tongji Results: Three microRNAs (hsa-mir-31, hsa-mir-16-2, and hsa-mir-484) were identified to Medical College, Huazhong University of Science and Technology, Wuhan be significantly and independently correlated with patient prognosis, and performed with good 430022, China stability.
    [Show full text]